Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Vansen Pharma Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Vansen Pharma Inc. | oknv_10k.htm |
| EX-31.1 - CERTIFICATION - Vansen Pharma Inc. | oknv_ex311.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, Maria Peralta, President, Chief Executive Officer and Chief Financial Officer of Okana Ventures, Inc., hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1)
|
the annual report on Form 10-K of Okana Ventures, Inc. for the year ended December 31, 2012 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Okana Ventures, Inc.
|
|
Date: April 12, 2013
|
By:
|
/s/ Maria Peralta | |
| Maria Peralta | |||
| Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director | |||
| (Principal Executive and Principal Financial and Accounting Officer and Director) |